Pharma Pulse 4/11/24: 1/3 of Americans Have Skipped Healthcare Visit Due to Inability to Pay, MedQuest Names New CCIO & more
The latest news for pharma industry insiders.
If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
The average American can afford a maximum of a $97 for out-of-pocket healthcare expenses.
As medical practices owned by private equity firms fuel overbilling, a payment tool also backed by such investors helps insurers boost their profits.
MedQuest Associates (MedQuest), has selected Dr. Aalpen Patel as Chief Clinical and Innovation Officer. Dr. Patel joined on March 18 in a new role overseeing all functions related to clinical practices and innovation in product development and care delivery. He reports to CEO Jason Howard and serves on the company’s Executive Leadership Council.
Conversations like Marie Teil’s on the Pharmaceutical Executive podcast are crucial in shedding light on the data gap faced by women of childbearing age and opportunities for change. Listen below!
https://lnkd.in/e2Q_sMbj
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

